Atommap Corp

SEC filing

Biotechnology · New York, NY

Form D on EDGAR

Amount raised$31.1Msold at filing

Total offering$59.6M$28.5M still open

Investors in the raise29count reported to the SEC

FiledMar 20, 2026first sale Mar 6, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Keith LoebnerDirector

Huafeng XuExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.